"Erythropoiesis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The production of red blood cells (ERYTHROCYTES). In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction.
Descriptor ID |
D004920
|
MeSH Number(s) |
G04.152.825.414 G09.188.343.414
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Erythropoiesis".
Below are MeSH descriptors whose meaning is more specific than "Erythropoiesis".
This graph shows the total number of publications written about "Erythropoiesis" by people in this website by year, and whether "Erythropoiesis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 1 | 0 | 1 |
2017 | 10 | 7 | 17 |
2018 | 7 | 8 | 15 |
2019 | 2 | 1 | 3 |
2020 | 2 | 0 | 2 |
2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Erythropoiesis" by people in Profiles.
-
Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2. Stem Cell Reports. 2021 05 11; 16(5):1165-1181.
-
Human Erythroid Progenitors Are Directly Infected by SARS-CoV-2: Implications for Emerging Erythropoiesis in Severe COVID-19 Patients. Stem Cell Reports. 2021 03 09; 16(3):428-436.
-
A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients. Crit Rev Clin Lab Sci. 2020 09; 57(6):415-431.
-
EPO in Patients With COVID-19: More Than an Erythropoietic Hormone. Am J Kidney Dis. 2020 09; 76(3):441.
-
Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19. Am J Kidney Dis. 2020 09; 76(3):303-305.
-
A systems biology pipeline identifies regulatory networks for stem cell engineering. Nat Biotechnol. 2019 07; 37(7):810-818.
-
Salubrinal, a novel inhibitor of eIF-2a dephosphorylation, promotes erythropoiesis at early stage targeted by ufmylation pathway. J Cell Physiol. 2019 08; 234(10):18560-18570.
-
Deubiquitylase USP7 regulates human terminal erythroid differentiation by stabilizing GATA1. Haematologica. 2019 11; 104(11):2178-2187.
-
Multiple environmental stressors induce complex transcriptomic responses indicative of phenotypic outcomes in Western fence lizard. BMC Genomics. 2018 Dec 05; 19(1):877.
-
TET2 deficiency leads to stem cell factor-dependent clonal expansion of dysfunctional erythroid progenitors. Blood. 2018 11 29; 132(22):2406-2417.